These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31968225)
21. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors. Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Thordarson G; Slusher N; Leong H; Ochoa D; Rajkumar L; Guzman R; Nandi S; Talamantes F Breast Cancer Res; 2004; 6(4):R423-36. PubMed ID: 15217511 [TBL] [Abstract][Full Text] [Related]
23. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor. Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741 [TBL] [Abstract][Full Text] [Related]
24. Expression and localisation of oestrogen and progesterone receptors in the bovine mammary gland during development, function and involution. Schams D; Kohlenberg S; Amselgruber W; Berisha B; Pfaffl MW; Sinowatz F J Endocrinol; 2003 May; 177(2):305-17. PubMed ID: 12740019 [TBL] [Abstract][Full Text] [Related]
25. Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc. Kundel DW; Stromquist E; Greene AL; Zhdankin O; Regal RR; Rose-Hellekant TA Transgenic Res; 2012 Apr; 21(2):393-406. PubMed ID: 21863248 [TBL] [Abstract][Full Text] [Related]
26. RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells. Wang X; Feng S; Zhang H; Wang Y; Cui Y; Wang Z; Liu J; Zou W Mol Biol Rep; 2011 Feb; 38(2):761-8. PubMed ID: 20411337 [TBL] [Abstract][Full Text] [Related]
27. Estrogen Receptor-α and Progesterone Receptor Expression in Mammary Proliferative Lesions of Female Pet Rabbits. Degner S; Schoon HA; Laik-Schandelmaier C; Aupperle-Lellbach H; Schöniger S Vet Pathol; 2018 Nov; 55(6):838-848. PubMed ID: 30114981 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. Métivier R; Penot G; Carmouche RP; Hübner MR; Reid G; Denger S; Manu D; Brand H; Kos M; Benes V; Gannon F EMBO J; 2004 Sep; 23(18):3653-66. PubMed ID: 15343269 [TBL] [Abstract][Full Text] [Related]
29. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice. Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597 [TBL] [Abstract][Full Text] [Related]
30. Activation and inhibition of the AP-1 complex in human breast cancer cells. Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534 [TBL] [Abstract][Full Text] [Related]
31. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Petz LN; Ziegler YS; Schultz JR; Nardulli AM Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847 [TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110 [TBL] [Abstract][Full Text] [Related]
33. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Nesterova MV; Cho-Chung YS Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549 [TBL] [Abstract][Full Text] [Related]
34. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells. Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224 [TBL] [Abstract][Full Text] [Related]
35. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of melatonin anticancer effects. Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373 [TBL] [Abstract][Full Text] [Related]
38. Arsenite and cadmium promote the development of mammary tumors. Divekar SD; Li HH; Parodi DA; Ghafouri TB; Chen R; Cyrus K; Foxworth AE; Fornace AJ; Byrne C; Martin MB Carcinogenesis; 2020 Jul; 41(7):1005-1014. PubMed ID: 31646340 [TBL] [Abstract][Full Text] [Related]
39. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice. Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471 [TBL] [Abstract][Full Text] [Related]
40. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]